Stabilitech appoints new CEO

Dr Barbara Domayne-Hayman has joined Stabilitech as CEO. Barbara was previously Commercial Director at Arrow Therapeutics prior to their acquisition by AstraZeneca. Stabilitech is a privately held company based in London, with technology that stabilises vaccines and other biological products, removing the need for refrigeration.